LMED — LataMed AI Share Price
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.26 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -3.64% | ||
| Return on Equity | -9.15% | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 31st Dec | Unit | 2021 | 2022 | 2023 | 2024 | 2025 | 2026E | 2027E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
LataMed AI Corp., formerly Catalyst Crew Technologies Corp. is a Venezuela-based company primarily active in the Healthcare Technology sector. The Company is digital health and artificial intelligence technology enterprise, focusing on building telehealth infrastructure, healthcare coordination tools, analytics capabilities, and AI-enabled healthcare solutions for emerging markets. Such technologies are designed d to support healthcare access, patient engagement, provider coordination, emergency medical response, pharmacy integration, insurance accessibility, payment solutions, and data-driven healthcare operations, with an initial regional focus on Latin American markets. The Company owns intellectual property assets relating to its artificial intelligence-enabled healthcare analytics platform, including issued patents and proprietary software, while the modules are in development.
Directors
- Last Annual
- December 31st, 2025
- Last Interim
- June 30th, 2026
- Incorporated
- September 11th, 2008
- Public Since
- October 13th, 2010
- No. of Shareholders
- 149
- No. of Employees
- 3
- Sector
- Office Equipment
- Industry
- Technology
- Exchange
Pink Sheets on Nasdaq
- Shares in Issue
- 36,134,795

- Address
- Av. Romulo Gallegos con Av. Las Palmas, CARACAS, 1071
- Web
- https://latamed.ai
- Phone
- +1 3072164405
- Auditors
- Beckles & Co
Upcoming Events for LMED
Similar to LMED
CANON
Pink Sheets on Nasdaq
Dynasil of America
Pink Sheets on Nasdaq
Electro Optical Systems
Pink Sheets on Nasdaq
Global Payment Technologies
Pink Sheets on Nasdaq
Saguaro Holdings
Pink Sheets on Nasdaq
FAQ
As of Today at 03:45 UTC, shares in LataMed AI are trading at $0.05. This share price information is delayed by 15 minutes.
Shares in LataMed AI last closed at $0.05 and the price had moved by -61.54% over the past 365 days. In terms of relative price strength the LataMed AI share price has underperformed the S&P500 Index by -66.44% over the past year.
There is no consensus recommendation for this security.
Find out moreLataMed AI does not currently pay a dividend.
LataMed AI does not currently pay a dividend.
LataMed AI does not currently pay a dividend.
To buy shares in LataMed AI you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $0.05, shares in LataMed AI had a market capitalisation of $1.81m.
Here are the trading details for LataMed AI:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: LMED
Based on an overall assessment of its quality, value and momentum LataMed AI is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like LataMed AI. Over the past six months, its share price has underperformed the S&P500 Index by -85.38%.
As of the last closing price of $0.05, shares in LataMed AI were trading -96.65% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The LataMed AI PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.05.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on LataMed AI's directors





